Late Breaking Trials

Moderator(s)

• 

  Julianne Stoughton, MD

  Assistant Professor in Vascular Surgery Harvard Medical School
  Mass General Vascular Center: Vascular and Endovascular Surgery
  Boston, Massachusetts, United States
• 

  Mikel Sadek, MD

  Director, NYU Langone Vein Center
  New York University Langone Health
  New York City, New York, United States
• 

  Efthymios Avgerinos, MD

  Associate Professor of Vascular Surgery
  University of Athens, School of Medicine
  Athens, Attiki, Greece

Presentations:

• 9:15 AM – 9:23 AM  

  High Intensity Focused Ultrasound (HIFU) For Venous Insufficiency: Results From the First Multicenter Trial:
  

  Speaker: Steve Elias, MD – Englewood Hospital

  Co-Author: Antonios Gasparis, MD – Northwell Health
• 9:23 AM – 9:31 AM  

  Venous Stent for the Iliofemoral Vein Investigational Clinical Trial using the Duo Venous Stent System: A Subanalysis of The VIVID Trial
  

  Speaker: Kush Desai, MD – Northwestern University Feinberg School of Medicine
• 9:31 AM – 9:39 AM  

  An open label first in man usability and safety investigation with an intravenous injection technique to deploy tumescence during laser ablation of the great saphenous vein.
  

  Speaker: Michael L. Akesson, MD,SCIR – Scandinavian Venous Centre

  Co-Author: Anders JB Lundell, MD – Scandinavian Venous Centre
• 9:39 AM – 9:47 AM  

  Invited Talk: Raising the Bar: A New Era in Venous Education and Certification
  

  Speaker: Julianne Stoughton, MD – Mass General Vascular Center: Vascular and Endovascular Surgery
• 9:47 AM – 9:55 AM  

  Impact of the VenoValve on the quality of life of patients with isolated deep Venous Reflux
  

  Speaker: Cassius Iyad Ochoa Chaar, MD, MPH, MS – Yale School of Medicine, Yale University
• 9:55 AM – 10:03 AM  

  Non Expert AI assisted compression US can potentially reduce the need for std vascular lab DVT and patient waiting times
  

  Speaker: Efthymios "Makis" Avgerinos, MD – University of Athens, School of Medicine
• 10:03 AM – 10:11 AM  

  Perivascular Dexamethasone to Prevent Post-Thrombotic Syndrome after Thrombus Removal in Deep Vein Thrombosis – Mid- and Long-Term Outcomes from the DEXTERITY Studies
  

  Speaker: David Dexter, II, MD – Macon and Joan Brock Virginia Health Sciences. Old Dominion University Eastern Virginia Medical School